PRTK Annual Total Liabilities
$343.58 M
+$31.92 M+10.24%
31 December 2022
Summary:
As of January 21, 2025, PRTK annual total liabilities is $343.58 million, with the most recent change of +$31.92 million (+10.24%) on December 31, 2022. During the last 3 years, it has risen by +$52.85 million (+18.18%).PRTK Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTK Quarterly Total Liabilities
$347.16 M
+$7.29 M+2.15%
30 June 2023
Summary:
As of January 21, 2025, PRTK quarterly total liabilities is $347.16 million, with the most recent change of +$7.29 million (+2.15%) on June 30, 2023. Over the past year, it has increased by +$34.09 million (+10.89%).PRTK Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTK Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10.2% | +10.9% |
| 3 y3 years | +18.2% | +19.5% |
| 5 y5 years | +323.0% | +43.3% |
PRTK Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | at high | at high |
Paratek Pharmaceuticals Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | $347.16 M(+2.1%) |
| Mar 2023 | - | $339.87 M(-1.1%) |
| Dec 2022 | $343.58 M(+10.2%) | $343.58 M(+6.2%) |
| Sept 2022 | - | $323.47 M(+3.3%) |
| June 2022 | - | $313.06 M(+0.8%) |
| Mar 2022 | - | $310.46 M(-0.4%) |
| Dec 2021 | $311.66 M(+11.7%) | $311.66 M(+8.5%) |
| Sept 2021 | - | $287.34 M(+3.0%) |
| June 2021 | - | $278.88 M(+0.2%) |
| Mar 2021 | - | $278.29 M(-0.3%) |
| Dec 2020 | $279.11 M(-4.0%) | $279.11 M(+0.2%) |
| Sept 2020 | - | $278.57 M(-4.1%) |
| June 2020 | - | $290.58 M(+0.6%) |
| Mar 2020 | - | $288.90 M(-0.6%) |
| Dec 2019 | $290.73 M(+15.1%) | $290.73 M(-0.9%) |
| Sept 2019 | - | $293.38 M(+1.1%) |
| June 2019 | - | $290.25 M(+13.2%) |
| Mar 2019 | - | $256.41 M(+1.5%) |
| Dec 2018 | $252.61 M(+211.0%) | $252.61 M(-2.9%) |
| Sept 2018 | - | $260.22 M(+7.4%) |
| June 2018 | - | $242.34 M(+200.9%) |
| Mar 2018 | - | $80.53 M(-0.9%) |
| Dec 2017 | $81.22 M(+26.6%) | $81.22 M(+16.3%) |
| Sept 2017 | - | $69.86 M(+1.6%) |
| June 2017 | - | $68.75 M(+9.9%) |
| Mar 2017 | - | $62.56 M(-2.5%) |
| Dec 2016 | $64.14 M(+43.6%) | $64.14 M(+39.0%) |
| Sept 2016 | - | $46.14 M(-12.9%) |
| June 2016 | - | $52.97 M(+5.2%) |
| Mar 2016 | - | $50.36 M(+12.7%) |
| Dec 2015 | $44.68 M(+203.0%) | $44.68 M(+10.1%) |
| Sept 2015 | - | $40.59 M(+112.4%) |
| June 2015 | - | $19.11 M(+28.7%) |
| Mar 2015 | - | $14.85 M(+0.7%) |
| Dec 2014 | $14.74 M | $14.74 M(+458.7%) |
| Sept 2014 | - | $2.64 M(+5.9%) |
| June 2014 | - | $2.49 M(+28.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | $1.94 M(+0.4%) |
| Dec 2013 | $1.93 M(-27.6%) | $1.93 M(-37.0%) |
| Sept 2013 | - | $3.06 M(+126.5%) |
| June 2013 | - | $1.35 M(-36.1%) |
| Mar 2013 | - | $2.11 M(-20.6%) |
| Dec 2012 | $2.66 M(-21.7%) | $2.66 M(-21.0%) |
| Sept 2012 | - | $3.37 M(+8.1%) |
| June 2012 | - | $3.12 M(+18.3%) |
| Mar 2012 | - | $2.64 M(-22.4%) |
| Dec 2011 | $3.40 M(-66.0%) | $3.40 M(+39.5%) |
| Sept 2011 | - | $2.44 M(-37.6%) |
| June 2011 | - | $3.90 M(-40.6%) |
| Mar 2011 | - | $6.57 M(-34.3%) |
| Dec 2010 | $10.00 M(-58.6%) | $10.00 M(-30.4%) |
| Sept 2010 | - | $14.35 M(-14.6%) |
| June 2010 | - | $16.80 M(-15.6%) |
| Mar 2010 | - | $19.92 M(-17.5%) |
| Dec 2009 | $24.15 M(-68.8%) | $24.15 M(-10.5%) |
| Sept 2009 | - | $26.99 M(+485.9%) |
| June 2009 | - | $4.61 M(-17.6%) |
| Mar 2009 | - | $5.59 M(-92.8%) |
| Dec 2008 | $77.36 M(+20.7%) | $77.36 M(+1582.1%) |
| Sept 2008 | - | $4.60 M(-7.1%) |
| June 2008 | - | $4.95 M(-91.7%) |
| Mar 2008 | - | $59.35 M(-7.4%) |
| Dec 2007 | $64.07 M(+926.8%) | $64.07 M(-3.5%) |
| Sept 2007 | - | $66.43 M(-6.9%) |
| June 2007 | - | $71.39 M(+814.0%) |
| Mar 2007 | - | $7.81 M(+25.2%) |
| Dec 2006 | $6.24 M(-94.5%) | $6.24 M(+2.0%) |
| Sept 2006 | - | $6.12 M(-0.3%) |
| June 2006 | - | $6.14 M(-94.6%) |
| Mar 2006 | - | $114.62 M(+1.7%) |
| Dec 2005 | $112.71 M(+31.6%) | $112.71 M(+31.6%) |
| Dec 2004 | $85.64 M(+75.3%) | $85.64 M |
| Dec 2002 | $48.84 M(+815.5%) | - |
| Dec 2001 | $5.33 M | - |
FAQ
- What is Paratek Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for Paratek Pharmaceuticals?
- What is Paratek Pharmaceuticals annual total liabilities year-on-year change?
- What is Paratek Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for Paratek Pharmaceuticals?
- What is Paratek Pharmaceuticals quarterly total liabilities year-on-year change?
What is Paratek Pharmaceuticals annual total liabilities?
The current annual total liabilities of PRTK is $343.58 M
What is the all time high annual total liabilities for Paratek Pharmaceuticals?
Paratek Pharmaceuticals all-time high annual total liabilities is $343.58 M
What is Paratek Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, PRTK annual total liabilities has changed by +$31.92 M (+10.24%)
What is Paratek Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of PRTK is $347.16 M
What is the all time high quarterly total liabilities for Paratek Pharmaceuticals?
Paratek Pharmaceuticals all-time high quarterly total liabilities is $347.16 M
What is Paratek Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, PRTK quarterly total liabilities has changed by +$34.09 M (+10.89%)